Centene Receives Regulatory Approval For The Fidelis Care Transaction From New York Department Of Health And New York Department Of Financial Services
Go back to Centene Receives Regulatory Approval For The Fidelis Care Transaction From New York Department Of Health And New York Department Of Financial Services| CENTENE CORPORATION (NYSE: CNC) | Delayed: 63.73 +0.05 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.68 | 52 Week High | $75.57 | |||
| Open | $63.62 | 52 Week Low | $47.36 | |||
| Day High | $64.25 | P/E | 22.21 | |||
| Day Low | $63.39 | EPS | $2.87 | |||
| Volume | 2,021,817 | |||||
